| 17alpha-ethynylestradiol | increases expression | ISO | RGD:1313670 | 6480464 | Ethinyl Estradiol results in increased expression of UPP1 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:1305566 | 6480464 | Ethinyl Estradiol results in increased expression of UPP1 mRNA | CTD | PMID:17557909 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1313670 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UPP1 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of UPP1 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of UPP1 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1313670 | 6480464 | Tetrachlorodibenzodioxin affects the expression of UPP1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of UPP1 mRNA | CTD | PMID:20106945 PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1313670 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UPP1 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of UPP1 mRNA | CTD | PMID:16704738 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:1305566 | 6480464 | 2,4-dinitrotoluene affects the expression of UPP1 mRNA | CTD | PMID:21346803 |
| 3-methylcholanthrene | increases expression | ISO | RGD:1313670 | 6480464 | Methylcholanthrene results in increased expression of UPP1 mRNA | CTD | PMID:20713471 |
| 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:1313670 | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of UPP1 mRNA | CTD | PMID:18648102 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | increases expression | ISO | RGD:1305566 | 6480464 | Oxazolone results in increased expression of UPP1 mRNA | CTD | PMID:21893156 |
| 5-fluorouracil | increases expression | EXP | | 6480464 | Fluorouracil results in increased expression of UPP1 mRNA | CTD | PMID:15109396 |
| 5-fluorouracil | affects response to substance | ISO | RGD:1313670 | 6480464 | UPP1 protein affects the susceptibility to Fluorouracil | CTD | PMID:15772079 |
| 5-fluorouracil | multiple interactions | ISO | RGD:1313670 | 6480464 | [UPP1 protein results in increased metabolism of Uridine] which affects the susceptibility to Fluorouracil | CTD | PMID:15772079 |
| 5-fluorouracil | affects response to substance | EXP | | 6480464 | UPP1 affects the susceptibility to Fluorouracil | CTD | PMID:15067352 |
| 5-fluorouracil | increases expression | EXP | | 6480464 | Fluorouracil results in increased expression of UPP1 protein | CTD | PMID:15331170 |
| adenosine | increases metabolic processing | ISO | RGD:1313670 | 6480464 | UPP1 protein results in increased metabolism of Adenosine | CTD | PMID:15772079 |
| aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of UPP1 protein | CTD | PMID:20106945 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1313670 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of UPP1 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of UPP1 mRNA | CTD | PMID:21632981 |
| benzo[a]pyrene | increases expression | ISO | RGD:1313670 | 6480464 | Benzo(a)pyrene results in increased expression of UPP1 mRNA | CTD | PMID:22228805 |
| bicalutamide | increases expression | EXP | | 6480464 | bicalutamide results in increased expression of UPP1 mRNA | CTD | PMID:15638997 |
| bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of UPP1 mRNA | CTD | PMID:20678512 |
| bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of UPP1 mRNA | CTD | PMID:20170705 |
| cadmium atom | increases expression | EXP | | 6480464 | Cadmium results in increased expression of UPP1 mRNA | CTD | PMID:21172416 |
| calciol | decreases expression | ISO | RGD:1313670 | 6480464 | Cholecalciferol results in decreased expression of UPP1 mRNA | CTD | PMID:16508948 |
| cefaloridine | increases expression | ISO | RGD:1305566 | 6480464 | Cephaloridine results in increased expression of UPP1 mRNA | CTD | PMID:18500788 |
| cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of UPP1 mRNA | CTD | PMID:19376846 PMID:19320972 |
| cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of UPP1 mRNA | CTD | PMID:19320972 PMID:19376846 |
| copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of UPP1 mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of UPP1 mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of UPP1 mRNA | CTD | PMID:19549813 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of UPP1 mRNA | CTD | PMID:20106945 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of UPP1 mRNA | CTD | PMID:20106945 PMID:21632981 |
| cytidine | increases metabolic processing | ISO | RGD:1313670 | 6480464 | UPP1 protein results in increased metabolism of Cytidine | CTD | PMID:15772079 |
| dibutyl phthalate | decreases expression | ISO | RGD:1313670 | 6480464 | Dibutyl Phthalate results in decreased expression of UPP1 mRNA | CTD | PMID:21266533 |
| diquat | increases expression | EXP | | 6480464 | Diquat results in increased expression of UPP1 mRNA | CTD | PMID:21172416 |
| doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of UPP1 mRNA | CTD | PMID:18510171 |
| guanosine | increases metabolic processing | ISO | RGD:1313670 | 6480464 | UPP1 protein results in increased metabolism of Guanosine | CTD | PMID:15772079 |
| hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of UPP1 mRNA | CTD | PMID:20044591 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of UPP1 mRNA | CTD | PMID:16984733 |
| menadione | affects expression | EXP | | 6480464 | Vitamin K 3 affects the expression of UPP1 mRNA | CTD | PMID:20044591 |
| N-methyl-N-nitrosurea | increases expression | ISO | RGD:1305566 | 6480464 | Methylnitrosourea results in increased expression of UPP1 mRNA | CTD | PMID:17412507 |
| nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of UPP1 mRNA | CTD | PMID:18651567 |
| pentobarbital | affects response to substance | ISO | RGD:1313670 | 6480464 | UPP1 protein affects the susceptibility to Pentobarbital | CTD | PMID:15772079 |
| pentobarbital | multiple interactions | ISO | RGD:1313670 | 6480464 | [UPP1 protein results in increased metabolism of Uridine] which affects the susceptibility to Pentobarbital | CTD | PMID:15772079 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of UPP1 mRNA | CTD | PMID:19084549 |
| phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of UPP1 mRNA | CTD | PMID:19159669 |
| pirinixic acid | decreases expression | ISO | RGD:1313670 | 6480464 | pirinixic acid results in decreased expression of UPP1 mRNA | CTD | PMID:17426115 |
| pirinixic acid | increases expression | ISO | RGD:1313670 | 6480464 | pirinixic acid results in increased expression of UPP1 mRNA | CTD | PMID:18301758 PMID:20813756 |
| pirinixic acid | increases expression | ISO | RGD:1313670 | 6480464 | pirinixic acid results in increased expression of UPP1 mRNA | CTD | PMID:20813756 PMID:18301758 |
| pyrimidine | increases metabolic processing | ISO | RGD:1313670 | 6480464 | UPP1 protein results in increased metabolism of pyrimidine | CTD | PMID:15772079 |
| succimer | multiple interactions | ISO | RGD:1313670 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of UPP1 mRNA | CTD | PMID:21641980 |
| tert-butyl hydroperoxide | increases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in increased expression of UPP1 mRNA | CTD | PMID:15336504 |
| thimerosal | increases expression | EXP | | 6480464 | Thimerosal results in increased expression of UPP1 mRNA | CTD | PMID:16870260 |
| trimellitic anhydride | increases expression | ISO | RGD:1305566 | 6480464 | trimellitic anhydride results in increased expression of UPP1 mRNA | CTD | PMID:21893156 |
| uridine | affects abundance | ISO | RGD:1313670 | 6480464 | UPP1 protein affects the abundance of Uridine | CTD | PMID:15772079 |
| uridine | multiple interactions | ISO | RGD:1313670 | 6480464 | [UPP1 protein results in increased metabolism of Uridine] which affects the susceptibility to Pentobarbital; more ... | CTD | PMID:15772079 |
| uridine | increases metabolic processing | ISO | RGD:1313670 | 6480464 | UPP1 protein results in increased metabolism of Uridine | CTD | PMID:15772079 |
| valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of UPP1 mRNA | CTD | PMID:19101580 |
| valproic acid | decreases expression | ISO | RGD:1313670 | 6480464 | Valproic Acid results in decreased expression of UPP1 mRNA | CTD | PMID:19136453 |